Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Category Sector Equity Healthcare
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
118.20p
1.00p (+0.85%)
Fund Code
LGGPA
B0CNH38
GB00B0CNH387
Prices updated as at 09 May 2025
|
Prices in GBX
Investment objective
The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied. Therefore, the Fund’s performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors. The Benchmark Index is comprised of shares in companies engaged in health, pharmaceuticals and biotechnology. The Fund is a Replicating Fund as it seeks to replicate as closely as possible the constituents of the Benchmark Index by holding all, or substantially all, of the assets comprising the Benchmark Index in similar proportions to their weightings in the Benchmark Index. The Fund will have at least 90% exposure to assets that are included in the Benchmark Index.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Portfolio as of 31/03/2025
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Stock style
Large value
41.38%
% Weight
Value
Core
Growth
Large
41
20
25
Medium
3
6
3
Small
0
0
0
Valuation
Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare
17.24
2.25
4.03
14.67
Growth rate
Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare
9.81%
1.94%
2.05%
Top 10 holdings
Security name | Sector | Country | % of assets | |
---|---|---|---|---|
1 | Eli Lilly and Co | - | United States | 8.67 |
2 | UnitedHealth Group Inc | - | United States | 6.48 |
3 | Johnson & Johnson | - | United States | 5.38 |
4 | AbbVie Inc | - | United States | 4.91 |
5 | Roche Holding AG | - | Switzerland | 3.15 |
6 | Abbott Laboratories | - | United States | 3.08 |
7 | Merck & Co Inc | - | United States | 3.04 |
8 | Novartis AG Registered Shares | - | Switzerland | 2.97 |
9 | Novo Nordisk AS Class B | - | Denmark | 2.92 |
10 | AstraZeneca PLC | - | United Kingdom | 2.55 |
Assets in top 10 holdings %
43.15%
Total no. of equity holdings
177.00
Total no. of bond holdings
-
Stock sectors
Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare
0.34%
Basic materials
Con cyclical
Financial svs
Real estate
0.00%
Comm services
Energy
Industrials
Technology
99.66%
Con defensive
Healthcare
Utilities